Potential conflict of interest: Nothing to report.
Neutralization of lipopolysaccharide effects in liver diseases, the quest for the holy grail†
Version of Record online: 2 MAY 2011
Copyright © 2011 American Association for the Study of Liver Diseases
Volume 54, Issue 1, page 376, July 2011
How to Cite
Galbois, A., Thabut, D., Moreau, R. and Lebrec, D. (2011), Neutralization of lipopolysaccharide effects in liver diseases, the quest for the holy grail. Hepatology, 54: 376. doi: 10.1002/hep.24186
- Issue online: 24 JUN 2011
- Version of Record online: 2 MAY 2011
- Accepted manuscript online: 12 JAN 2011 06:50PM EST
- 2High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats. HEPATOLOGY 2007; 46: 1893-1906., , , , , , et al.